Business Analytics in Life Sciences

Business Analytics in Life Sciences

The Time is Ripe for a Technology Revamp in Clinical Trials

RELEASE DATE
24-Jun-2016
REGION
Europe
Research Code: MC28-01-00-00-00
SKU: LS00267-EU-MR_18867

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
LS00267-EU-MR_18867

$3,000.00

$2,250.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.

Table of Contents

Key Findings

Executive Summary

Current Challenges

Fallacies of Traditional Patient Recruitment Methods

EHR Data Use Cases are Expected to Evolve

EHR4CR Initiative in Europe Promotes Patient Data Usage in Trials

3 Backbones of a Successful Data-driven Approach to Clinical Trials

The UK is a Forerunner in Terms of Enabling Access to its National EHR Database for Clinical Research Purposes

Number of Clinical Studies has Increased Drastically—Only to Add Complexity and Costs

Trial Sponsors are Targeting Clinical Trials for Efficiency Gains

Key BA Applications for Clinical Trials

BA Solutions have Moved beyond KPI Dashboards

Evolution of Infrastructure Components and Data Repositories has Led to New BI Functionalities

Internet and Database Companies have Created New Repositories for Unstructured Data Management

BI Tools are Empowering Business and End Users

Advanced Analytics is not just Interactive Displays of Information

Future of Clinical Trials will Focus on Cost and Process Optimisation

Comparative Analysis of Key Vendors in BA for Life Sciences

Recommendations for Enterprises

Recommendations for Vendors

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.
More Information
No Index No
Podcast No
Author Srikanth Venkataraman
WIP Number MC28-01-00-00-00
Is Prebook No